These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 18485150

  • 1. Bleeding risks of combination vs. single antiplatelet therapy: a meta-analysis of 18 randomized trials comprising 129,314 patients.
    Serebruany VL, Malinin AI, Ferguson JJ, Vahabi J, Atar D, Hennekens CH.
    Fundam Clin Pharmacol; 2008 Jun; 22(3):315-21. PubMed ID: 18485150
    [Abstract] [Full Text] [Related]

  • 2. Risk of bleeding complications with antiplatelet agents: meta-analysis of 338,191 patients enrolled in 50 randomized controlled trials.
    Serebruany VL, Malinin AI, Eisert RM, Sane DC.
    Am J Hematol; 2004 Jan; 75(1):40-7. PubMed ID: 14695631
    [Abstract] [Full Text] [Related]

  • 3. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines.
    Hankey GJ.
    Curr Med Res Opin; 2007 Jun; 23(6):1453-62. PubMed ID: 17559741
    [Abstract] [Full Text] [Related]

  • 4. Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.
    Motovska Z, Kala P.
    Clin Ther; 2008 Jun; 30 Pt 2():2191-202. PubMed ID: 19281914
    [Abstract] [Full Text] [Related]

  • 5. Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.
    Aronow HD, Steinhubl SR, Brennan DM, Berger PB, Topol EJ, CREDO Investigators.
    Am Heart J; 2009 Feb; 157(2):369-74. PubMed ID: 19185647
    [Abstract] [Full Text] [Related]

  • 6. An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trial.
    Wang TH, Bhatt DL, Fox KA, Steinhubl SR, Brennan DM, Hacke W, Mak KH, Pearson TA, Boden WE, Steg PG, Flather MD, Montalescot G, Topol EJ, CHARISMA Investigators.
    Eur Heart J; 2007 Sep; 28(18):2200-7. PubMed ID: 17673448
    [Abstract] [Full Text] [Related]

  • 7. Aspirin, clopidogrel, and warfarin: is the combination appropriate and effective or inappropriate and too dangerous?
    Hermosillo AJ, Spinler SA.
    Ann Pharmacother; 2008 Jun; 42(6):790-805. PubMed ID: 18477734
    [Abstract] [Full Text] [Related]

  • 8. Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy.
    Rossini R, Musumeci G, Lettieri C, Molfese M, Mihalcsik L, Mantovani P, Sirbu V, Bass TA, Della Rovere F, Gavazzi A, Angiolillo DJ.
    Am J Cardiol; 2008 Dec 15; 102(12):1618-23. PubMed ID: 19064015
    [Abstract] [Full Text] [Related]

  • 9. The effects of oral anticoagulants in patients with peripheral arterial disease: rationale, design, and baseline characteristics of the Warfarin and Antiplatelet Vascular Evaluation (WAVE) trial, including a meta-analysis of trials.
    WAVE Investigators.
    Am Heart J; 2006 Jan 15; 151(1):1-9. PubMed ID: 16368284
    [Abstract] [Full Text] [Related]

  • 10. Combination antiplatelet therapy in patients with peripheral arterial disease: is the best therapy aspirin, clopidogrel, or both?
    Mohler ER.
    Catheter Cardiovasc Interv; 2009 Jul 01; 74 Suppl 1():S1-6. PubMed ID: 19213065
    [Abstract] [Full Text] [Related]

  • 11. Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants.
    Lanas A, García-Rodríguez LA, Arroyo MT, Bujanda L, Gomollón F, Forné M, Aleman S, Nicolas D, Feu F, González-Pérez A, Borda A, Castro M, Poveda MJ, Arenas J, Investigators of the Asociación Española de Gastroenterología (AEG).
    Am J Gastroenterol; 2007 Mar 01; 102(3):507-15. PubMed ID: 17338735
    [Abstract] [Full Text] [Related]

  • 12. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
    De Stefano V, Za T, Rossi E, Vannucchi AM, Ruggeri M, Elli E, Micò C, Tieghi A, Cacciola RR, Santoro C, Gerli G, Vianelli N, Guglielmelli P, Pieri L, Scognamiglio F, Rodeghiero F, Pogliani EM, Finazzi G, Gugliotta L, Marchioli R, Leone G, Barbui T, GIMEMA CMD-Working Party.
    Haematologica; 2008 Mar 01; 93(3):372-80. PubMed ID: 18268279
    [Abstract] [Full Text] [Related]

  • 13. Bleeding risk of combined oral anticoagulant and antiplatelet therapy in cardiovascular disease.
    Verheugt FW.
    J Cardiovasc Risk; 1996 Apr 01; 3(2):229-32. PubMed ID: 8836868
    [Abstract] [Full Text] [Related]

  • 14. Network meta-analysis: simultaneous meta-analysis of common antiplatelet regimens after transient ischaemic attack or stroke.
    Thijs V, Lemmens R, Fieuws S.
    Eur Heart J; 2008 May 01; 29(9):1086-92. PubMed ID: 18349026
    [Abstract] [Full Text] [Related]

  • 15. Known knowns and known unknowns: risks associated with combination antithrombotic therapy.
    Johnson S.
    Thromb Res; 2008 May 01; 123 Suppl 1():S7-11. PubMed ID: 18829070
    [Abstract] [Full Text] [Related]

  • 16. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM, White CM, Coleman CI.
    Clin Ther; 2008 Aug 01; 30(8):1416-25. PubMed ID: 18803985
    [Abstract] [Full Text] [Related]

  • 17. The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes.
    Toth PP.
    Postgrad Med; 2009 Jan 01; 121(1):59-72. PubMed ID: 19179814
    [Abstract] [Full Text] [Related]

  • 18. Antiplatelet therapy use after discharge among acute myocardial infarction patients with in-hospital bleeding.
    Wang TY, Xiao L, Alexander KP, Rao SV, Kosiborod MN, Rumsfeld JS, Spertus JA, Peterson ED.
    Circulation; 2008 Nov 18; 118(21):2139-45. PubMed ID: 18981304
    [Abstract] [Full Text] [Related]

  • 19. Incidence of bleeding and compliance on prolonged dual antiplatelet therapy (aspirin + thienopyridine) following drug-eluting stent implantation.
    Latib A, Morici N, Cosgrave J, Airoldi F, Godino C, Brambilla N, Chieffo A, Bonizzoni E, Carlino M, Bedogni F, Montorfano M, Sangiorgi GM, Briguori C, Colombo A.
    Am J Cardiol; 2008 Dec 01; 102(11):1477-81. PubMed ID: 19026299
    [Abstract] [Full Text] [Related]

  • 20. Secondary stroke prevention with antiplatelet drugs: have we reached the ceiling?
    Diener HC.
    Int J Stroke; 2006 Feb 01; 1(1):4-8. PubMed ID: 18706062
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.